1. Targeting T cell exhaustion: emerging strategies in non-small cell lung cancer
   Xianqiang Liu et al, 2024, Frontiers in Immunology CrossRef
2. PD-L1 as a prognostic and predictive biomarker in neuroendocrine tumors of the lung: state of the art and future perspectives
   Francesca SANGUEDOLCE et al, 2021, Minerva Respiratory Medicine CrossRef
3. Tiragolumab (Anti-TIGIT) in SCLC: Skyscraper-02, a Towering Inferno
   Danielle Brazel et al, 2023, Lung Cancer: Targets and Therapy CrossRef
4. Differential Expression of PD-L1 in Central and Peripheral and TTF1-Positive and -Negative Small-Cell Lung Cancer
   Shili Yu et al, 2021, Frontiers in Medicine CrossRef
5. Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis
   Sicong Li et al, 2022, Frontiers in Immunology CrossRef
6. Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR
   Xiuman Zhou et al, 2020, Cell Communication and Signaling CrossRef
7. Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
   Elisa Giannetta et al, 2021, Frontiers in Endocrinology CrossRef
8. Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies
   Yizhou Zhang et al, 2024, mAbs CrossRef
9. Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta-Analysis
   Kunmin Xiao et al, 2021, Journal of Immunology Research CrossRef
10. Peptide-based PET imaging agent of tumor TIGIT expression
    Dinghu Weng et al, 2023, EJNMMI Research CrossRef
11. Ectopic Expression of TIGIT in Lung Adenocarcinoma and Its Clinical Significance
    Shuyan He et al, 2024, Critical Reviews in Eukaryotic Gene Expression CrossRef
12. Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis
    Huarong Cai et al, 2020, Frontiers in Oncology CrossRef
13. Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis
    Dan Zhang et al, 2022, World Journal of Surgical Oncology CrossRef